PCSA RSI Chart
Last 7 days
-7.7%
Last 30 days
16.3%
Last 90 days
-22.2%
Trailing 12 Months
-85.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2020 | 0 | 0 | 0 | 0 |
2016 | 80.7K | 80.7K | 22.5K | 0 |
2015 | 1.5M | 1.4M | 1.4M | 113.4K |
2014 | 391.7K | 762.1K | 1.1M | 1.5M |
2013 | 149.4K | 106.7K | 64.0K | 21.3K |
2012 | 0 | 0 | 0 | 192.1K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 07, 2024 | young david | bought | 51,525 | 2.4536 | 21,000 | pres. research & development |
Feb 06, 2024 | young david | bought | 50,504 | 2.5252 | 20,000 | pres. research & development |
Feb 01, 2024 | lin patrick | bought | 3,600 | 2.4 | 1,500 | chief business - strategy off |
Jan 31, 2024 | lin patrick | bought | 5,925 | 2.37 | 2,500 | chief business - strategy off |
Jan 30, 2024 | yorke justin w | bought | 21,544 | 2.693 | 8,000 | - |
Jan 30, 2024 | ng george k | bought | 27,000 | 2.7 | 10,000 | chief executive officer |
Jan 01, 2024 | young david | acquired | - | - | 1,675 | pres. research & development |
Jan 01, 2024 | bigora sian | sold (taxes) | -1,026 | 2.79 | -368 | chief development officer |
Jan 01, 2024 | bigora sian | acquired | - | - | 1,675 | chief development officer |
Jan 01, 2024 | young david | sold (taxes) | -1,445 | 2.79 | -518 | pres. research & development |
Which funds bought or sold PCSA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | STATE STREET CORP | sold off | -100 | -14,316 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 378 | 378 | -% |
May 15, 2024 | Main Street Group, LTD | new | - | 235 | 235 | -% |
May 15, 2024 | Coastal Bridge Advisors, LLC | sold off | -100 | -21,734 | - | -% |
May 15, 2024 | SABBY MANAGEMENT, LLC | new | - | 114,941,000 | 114,941,000 | 0.07% |
May 15, 2024 | Tower Research Capital LLC (TRC) | sold off | -100 | -400 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | new | - | 10,654 | 10,654 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | sold off | -100 | -6,249 | - | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | new | - | 56,987 | 56,987 | -% |
May 15, 2024 | Royal Bank of Canada | sold off | -100 | -15,000 | - | -% |
Unveiling Processa Pharmaceuticals, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Processa Pharmaceuticals, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Processa Pharmaceuticals, Inc. News
Income Statement (Quarterly) | |||||||||||||||||||||
Description | (%) Q/Q | 2020Q3 | 2016Q4 | 2016Q3 | 2016Q2 | 2016Q1 | 2015Q4 | 2015Q3 | 2015Q2 | 2015Q1 | 2014Q4 | 2014Q3 | 2014Q2 | 2014Q1 | 2013Q4 | 2013Q3 | 2013Q2 | 2013Q1 | 2012Q4 | 2012Q3 | 2012Q2 |
Revenue | 100.0% | 197 | 99.00 | - | - | 5.00 | 18.00 | 58.00 | - | 38.00 | 1,317 | 53.00 | 113 | 20.00 | 73.00 | 126 | 97.00 | 19.00 | 34.00 | 49.00 | 97.00 |
Gross Profit | - | - | - | - | - | 5.00 | -45.31 | 16.00 | 9.00 | 13.00 | -40.77 | 27.00 | 43.00 | 11.00 | 36.00 | 45.00 | 36.00 | 7.00 | - | 15.00 | 43.00 |
Operating Expenses | 1151.2% | 2,956 | 236 | 829 | 575 | 281 | 176 | 140 | 1,891 | 471 | 645 | 689 | 781 | 1,295 | 829 | - | - | - | - | - | - |
S&GA Expenses | - | 423 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
R&D Expenses | - | 533 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | 194.1% | 186 | 63.00 | 63.00 | 63.00 | 56.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | -Infinity% | -70.46 | - | - | - | - | -25* | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -Infinity% | -3,141 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -Infinity% | -3,071 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 71.9% | 9,945 | 5,787 | 8,083 | 10,090 | 12,432 | 8,620 | 18,604 | 21,658 | 24,301 | 26,464 | 29,025 | 31,138 | 33,338 | 25,214 | 9,589 | 10,011 | 10,012 | 10,883 | 10,821 | 11,306 | 12,078 |
Current Assets | 74.0% | 9,800 | 5,632 | 7,907 | 9,897 | 12,219 | 8,387 | 10,887 | 13,961 | 16,384 | 18,327 | 20,670 | 22,566 | 24,546 | 16,203 | 376 | 577 | 357 | 1,007 | 725 | 990 | 1,543 |
Cash Equivalents | 89.5% | 8,920 | 4,706 | 6,861 | 8,677 | 10,742 | 6,504 | 9,055 | 12,064 | 14,395 | 16,498 | 19,093 | 20,831 | 23,048 | 15,416 | 325 | 453 | 142 | 692 | 504 | 722 | 1,249 |
Net PPE | -5.4% | 2.00 | 3.00 | 3.00 | - | - | - | - | - | - | - | - | - | - | 484* | 3.00 | 5.00 | 7.00 | 9.00 | 11.00 | 13.00 | 15.00 |
Liabilities | 33.1% | 1,061 | 797 | 915 | 931 | 2,290 | 1,149 | 1,364 | 1,576 | 1,064 | 978 | 1,817 | 1,896 | 2,002 | 2,275 | 4,062 | 3,418 | 2,778 | 2,871 | 2,151 | 2,804 | 2,954 |
Current Liabilities | 38.3% | 1,011 | 731 | 826 | 821 | 2,161 | 999 | 1,193 | 1,571 | 1,058 | 971 | 1,226 | 1,161 | 1,096 | 1,221 | 2,658 | 1,898 | 1,246 | 1,192 | 292 | 783 | 725 |
Shareholder's Equity | 78.1% | 8,883 | 4,989 | 7,168 | 9,160 | 10,142 | 7,471 | 17,240 | 20,082 | 23,237 | 25,485 | 27,208 | 29,242 | 31,336 | 22,939 | 5,527 | 6,593 | 7,234 | 8,013 | 8,671 | 8,502 | 9,124 |
Retained Earnings | -3.6% | -78,100 | -75,369 | -73,000 | -70,900 | -68,269 | -64,247 | -51,235 | -45,200 | -40,100 | -36,823 | -33,600 | -30,652 | -27,495 | -25,395 | -15,661 | -12,589 | -11,856 | -10,982 | -10,207 | -9,344 | -8,374 |
Additional Paid-In Capital | 8.2% | 87,279 | 80,658 | 80,430 | 80,339 | 78,709 | 72,018 | 68,774 | 65,595 | 63,586 | 62,307 | 60,846 | 59,892 | 58,830 | 48,334 | 21,188 | 19,182 | 19,090 | 18,994 | 18,874 | 19,246 | 19,180 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | 29.00 | - | - | - | 29.00 | - | - | 22.00 | 20.00 | 18.00 | 16.00 | - |
Shares Outstanding | 122.1% | 2,856 | 1,286 | 1,232 | 1,227 | 1,227 | 802 | 810 | 797 | 792 | 786 | 759 | 770 | 729 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 10,200 | - | - | - | 33,800 | - | - | - | 95,400 | - | - | - | 22,000 | - | - | - | 44,800 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 5.8% | -2,000 | -2,123 | -1,739 | -2,085 | -2,114 | -2,497 | -2,974 | -2,330 | -1,802 | -2,726 | -1,552 | -2,193 | -2,243 | -2,275 | 29.00 | -350 | -546 | -613 | -721 | -807 | -607 |
Share Based Compensation | -34.7% | 168 | 257 | 143 | 319 | 342 | 2,777 | 3,214 | 2,009 | 829 | 1,120 | 1,114 | 865 | 308 | 2,373 | 165 | 94.00 | 99.00 | 116 | 269 | 66.00 | 59.00 |
Cashflow From Investing | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow From Financing | 20562.8% | 6,263 | -30.61 | -52.75 | - | 6,352 | -53.60 | -35.25 | - | -300 | 131 | -185 | -23.08 | 9,876 | 17,366 | -156 | 661 | -2.81 | 801 | 504 | 281 | 115 |
Buy Backs | - | - | - | - | - | - | - | - | - | 300 | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating Expenses | ||
Research and development expenses | $ 1,539,070 | $ 1,627,480 |
General and administrative expenses | 1,270,528 | 2,478,055 |
Operating Loss | (2,809,598) | (4,105,535) |
Other Income (Expense), net | 83,217 | 83,462 |
Net Loss | $ (2,726,381) | $ (4,022,073) |
Net Loss Per Common Share - Basic | $ (1.11) | $ (3.53) |
Net Loss Per Common Share - Diluted | $ (1.11) | $ (3.53) |
Weighted Average Common Shares Used to Compute Net Loss Per Common Shares - Basic | 2,466,523 | 1,138,573 |
Weighted Average Common Shares Used to Compute Net Loss Per Common Shares - Diluted | 2,466,523 | 1,138,573 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 8,920,363 | $ 4,706,197 |
Due from related parties | 22,295 | |
Prepaid expenses and other | 857,635 | 926,300 |
Total Current Assets | 9,800,293 | 5,632,497 |
Property and Equipment, net | 2,415 | 2,554 |
Other Assets | ||
Lease right-of-use assets, net of accumulated amortization | 136,489 | 146,057 |
Security deposit | 5,535 | 5,535 |
Total Other Assets | 142,024 | 151,592 |
Total Assets | 9,944,732 | 5,786,643 |
Current Liabilities | ||
Current maturities of lease liabilities | 89,680 | 83,649 |
Accounts payable | 455,368 | 311,617 |
Due to licensor | 189,000 | |
Due to related parties | 39 | |
Accrued expenses | 465,618 | 146,274 |
Total Current Liabilities | 1,010,666 | 730,579 |
Non-current Liabilities | ||
Non-current lease liabilities | 50,700 | 66,905 |
Total Liabilities | 1,061,366 | 797,484 |
Commitments and Contingencies | ||
Stockholders’ Equity | ||
Common stock, par value $0.0001, 100,000,000 shares authorized: 2,860,981 issued and 2,855,981 outstanding at March 31, 2024 and 1,291,000 issued and 1,286,000 outstanding at December 31, 2023 | 286 | 129 |
Additional paid-in capital | 87,278,542 | 80,658,111 |
Treasury stock at cost — 5,000 shares at March 31, 2024 and December 31, 2023 | (300,000) | (300,000) |
Accumulated deficit | (78,095,462) | (75,369,081) |
Total Stockholders’ Equity | 8,883,366 | 4,989,159 |
Total Liabilities and Stockholders’ Equity | $ 9,944,732 | $ 5,786,643 |